FeesSafety
Pluang+

Ocumetics reports positive 12-month results for new intraocular lens improving patients' vision and daily life.

Company Fundamentals
17 Sep 2026
TheNewswire
View Source
Bullish
Ocumetics reports positive 12-month results for new intraocular lens improving patients' vision and daily life.

Ocumetics Technology Corp. announced that its Group One clinical trial patients for a new accommodating intraocular lens have reached the 12-month follow-up milestone, showing continued vision improvement and safety. Patients reported enhanced ability to read, watch TV, recognize family, and perform daily activities, with one previously legally blind patient regaining vision sufficient to drive. These results support further clinical development and regulatory progress. The company is preparing for the next trial phase to evaluate safety and vision performance more extensively.

Ocumetics clinical trial progress is the subject, here is Pluang's Health-sector market snapshot as of Sep 17, 2026 19:42 WIB: Out of 91 priced US Health-sector stocks, 74 rose and 15 fell today. Notable movers include CRSP at USD 53.31 with a 1-day change of +2.11% and a Pluang order activity of 35% Sell / 65% Buy, OSCR at USD 33.02 with a 1-day change of +2.10% and 0% Sell / 100% Buy order activity, and TLRY at USD 4.01 with a 1-day change of +2.04%. Typical hold times on Pluang range from 14 to 76 days for these stocks.

More News

AI-119 Vulcan launches hardware solution to meet California's May 2027 AI safety mandate for frontier AI developers.

AI-119 Vulcan launches hardware solution to meet California's May 2027 AI safety mandate for frontier AI developers.

AI-119 Vulcan Project Research and Engineering Company has introduced a hardware-based security system to comply with California's Executive Order N-9-26, which mandates strict safety controls on frontier AI developers like OpenAI and Google by May 2...

Market News
Neutral
1 hour ago
Avalanche's AVAX fee burns remain below staking issuance, delaying net deflationary effect until at least 2026.

Avalanche's AVAX fee burns remain below staking issuance, delaying net deflationary effect until at least 2026.

Avalanche's AVAX token transaction fee burns totaled 17,330 AVAX projected for March 2026, which is still below the amount issued through staking rewards. The average daily fee burns are about 559 AVAX, indicating that the net deflationary effect—whe...

Protocol Fundamentals
Neutral
4 hours ago
XRP Ledger hit 222.4M transactions in Q2 2026, stablecoin holdings at $1.11B but date unknown for comparison.

XRP Ledger hit 222.4M transactions in Q2 2026, stablecoin holdings at $1.11B but date unknown for comparison.

The XRP Ledger recorded 222.4 million transactions in the second quarter of 2026, indicating high activity on the platform. Meanwhile, stablecoin holdings on the ledger stand at $1.11 billion, but the lack of a specific observation date for this figu...

Protocol Fundamentals
Neutral
4 hours ago
3 million sUSDS moved to new wallet; 1,389.6 ETH sent to Tornado Cash in 36 transactions.

3 million sUSDS moved to new wallet; 1,389.6 ETH sent to Tornado Cash in 36 transactions.

A wallet transferred 3 million sUSDS to a new wallet, followed by 1,389.6 Ether (ETH) being deposited into Tornado Cash through 36 separate transactions. The funds were exchanged before the ETH deposits, but it remains unclear which wallet managed th...

Market News
Neutral
4 hours ago
Critical flaw in Succinct's SP1 Rust verifier patched to prevent invalid proofs on mainnet

Critical flaw in Succinct's SP1 Rust verifier patched to prevent invalid proofs on mainnet

A high-severity bug in Succinct's SP1 zero-knowledge virtual machine affected native Rust verifier versions 6.0.0 to 6.8.0, allowing malicious provers to submit invalid proofs that the network could wrongly accept. The issue was due to a missing chec...

Protocol Fundamentals
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App